Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-07

Clinical Trial Update: Clinical Trial Comparing BL123 Versus Ketoconazole in Patients With Tinea Pedis [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing BL123 to ketoconazole for tinea pedis has completed; the snippet does not provide efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BL123
  • Ketoconazole (Ketoconazole)

Snippet

Sponsor: Gilberto De Nucci | Conditions: Tinea Pedis | Phase 2 | Status: COMPLETED